Sjogren's syndrome is a chronic multisystem autoimmune disease characterized by the exocrine glands inflammation, with subsequent hypofunction. More frequently lachrymal and salivary glands are interested with subsequent xerophthalmia and xerostomia. Sjogren's syndrome can be present in an idiopathic type or in association with other autoimmune diseases as rheumatoid arthritis, systemic lupus erythematosus, schlerodermia, etc. It interests mainly the women (with a ratio F:M=9:1) with an age between 40 and 60 years old. The disease prevalence varies from 0.4% to 4.8%. The glandular lesions determine in the time a volume reduction and a secretum quality alteration. The most frequent oral manifestations are xerostomia, that allows the establishment of caries, gingivitises, periodontal disease and oral candidiasis. The aim of this work was to perform a thorough review of the literature on Sjogren's syndrome, illustrating the most internationally accredited diagnostic criteria, the patient's management and therapeutical approach in the odontostomatological discipline. The Authors conclude that it doesn't exist a resolutive treatment of the disease. The therapy is only palliative, and is turned to the treatment of xerostomia and xerophthalmia, through systemic and aspecific sialogogues drugs. From the odontostomatological point of view, particularly useful results the domiciliary and professional oral hygiene to contrast the xerostomia effect on the oral structures.

Stomatological approach to Sjogren's syndrome: diagnosis, management and therapeutical timing / F., Minozzi; Galli, Massimo; Gallottini, Livio; Minozzi, Massimo; V., Unfer. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 13:3(2009), pp. 201-216.

Stomatological approach to Sjogren's syndrome: diagnosis, management and therapeutical timing

GALLI, Massimo;GALLOTTINI, Livio;MINOZZI, Massimo;
2009

Abstract

Sjogren's syndrome is a chronic multisystem autoimmune disease characterized by the exocrine glands inflammation, with subsequent hypofunction. More frequently lachrymal and salivary glands are interested with subsequent xerophthalmia and xerostomia. Sjogren's syndrome can be present in an idiopathic type or in association with other autoimmune diseases as rheumatoid arthritis, systemic lupus erythematosus, schlerodermia, etc. It interests mainly the women (with a ratio F:M=9:1) with an age between 40 and 60 years old. The disease prevalence varies from 0.4% to 4.8%. The glandular lesions determine in the time a volume reduction and a secretum quality alteration. The most frequent oral manifestations are xerostomia, that allows the establishment of caries, gingivitises, periodontal disease and oral candidiasis. The aim of this work was to perform a thorough review of the literature on Sjogren's syndrome, illustrating the most internationally accredited diagnostic criteria, the patient's management and therapeutical approach in the odontostomatological discipline. The Authors conclude that it doesn't exist a resolutive treatment of the disease. The therapy is only palliative, and is turned to the treatment of xerostomia and xerophthalmia, through systemic and aspecific sialogogues drugs. From the odontostomatological point of view, particularly useful results the domiciliary and professional oral hygiene to contrast the xerostomia effect on the oral structures.
2009
odontostomatological treatment; lachrymal glands; odontostomatological approach; salivary glands; differential diagnoses; sjogren's syndrome; management; sjögren's syndrome
01 Pubblicazione su rivista::01a Articolo in rivista
Stomatological approach to Sjogren's syndrome: diagnosis, management and therapeutical timing / F., Minozzi; Galli, Massimo; Gallottini, Livio; Minozzi, Massimo; V., Unfer. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 13:3(2009), pp. 201-216.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/230493
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 2
social impact